| Name | Title | Contact Details |
|---|---|---|
Geoff Riggs |
Chief Information Officer | Profile |
Family HealthCare Network is a private nonprofit organization that operates 20 sites, 16 of which are federally qualified health centers located throughout Tulare and Kings Counties. Our mission is to provide quality health care to everyone in the communities we serve. With more than 160 medical and dental providers in our network, we provide access to a wide range of coordinated health services. FHCN also offers pharmacy services, free transportation, and extended evening and weekend hours. FHCN is recognized by the National Committee for Quality Assurance (NCQA) as a Level 3 Patient Centered Medical Home and is dually recognized by The Joint Commission with its Gold Seal of Approval® for Patient Quality and Safety and as a Patient Centered Primary Medical Home.
DUOJECT MEDICAL SYSTEMS, INC is a Bromont, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cure International is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Lemoyne, PA. To find more information about Cure International, please visit www.cureinternational.org
BioAtla was founded in 2007 and employs deep expertise in protein engineering to develop better monoclonal antibody and other protein therapeutics. Our suite of proprietary technologies (protected by more than 70 issued patents and patent applications) has enabled us to develop dozens of novel therapeutic proteins for our partners and our own pipeline. We accelerate the process from target discovery to manufacturing and preclinical studies by creating drugs with more selective targeting, greater affinity, and more cost-efficient and predictable manufacturing. In the process we also create valuable, protectable IP that gives our partners significant competitive advantage. The culmination of our protein evolution technologies is our Conditionally Active Biologics (CAB)platform. Monoclonal antibodies or enzymes can be engineered for selective conditional activation, i.e. the protein`s functions are designed to modulate with changes in microphysical conditions (e.g., pH level, oxidation, temperature, pressure concentration, presence of certain ions, hydrophobicity and competing protein binding). Tumors and other kinds of diseased tissue give rise to unique localized conditions distinct from normal tissue. CAB designed monoclonal antibodies can be programmed to deliver an ADC payload and/or recruit the immune response to specific sites and conditions in the body.
Fifth Eye`s early warning system continuously forecasts patient trajectory, giving doctors and nurses a heads up about impending trouble hours in advance of other methods.